Erik R. Olson

1.1k total citations
22 papers, 918 citations indexed

About

Erik R. Olson is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Erik R. Olson has authored 22 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in Erik R. Olson's work include CRISPR and Genetic Engineering (6 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (5 papers). Erik R. Olson is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (5 papers). Erik R. Olson collaborates with scholars based in United States, Slovakia and Australia. Erik R. Olson's co-authors include J. Gary Meszaros, Jennifer E. Naugle, David M. Roth, Paul A. Insel, James S. Swaney, Joshua A. Bomser, Xiaojin Zhang, Patricia E. Shamhart, Sally E. Dickinson and Kathleen J. Doane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Erik R. Olson

22 papers receiving 905 citations

Peers

Erik R. Olson
Meimei Yin United States
Michal Entin‐Meer Israel
Somy Yoon South Korea
Jianyuan Chai United States
Balkrishna Chaube India
Kwang Seok Kim South Korea
Dennis A. Ricupero United States
Jianhua Cui United States
Jiongyu Hu China
Meimei Yin United States
Erik R. Olson
Citations per year, relative to Erik R. Olson Erik R. Olson (= 1×) peers Meimei Yin

Countries citing papers authored by Erik R. Olson

Since Specialization
Citations

This map shows the geographic impact of Erik R. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik R. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik R. Olson more than expected).

Fields of papers citing papers by Erik R. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik R. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik R. Olson. The network helps show where Erik R. Olson may publish in the future.

Co-authorship network of co-authors of Erik R. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik R. Olson. A scholar is included among the top collaborators of Erik R. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik R. Olson. Erik R. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aronovich, Elena L., Jason Bell, Erik R. Olson, et al.. (2017). Prolonged Expression of Secreted Enzymes in Dogs After Liver-Directed Delivery of Sleeping Beauty Transposons: Implications for Non-Viral Gene Therapy of Systemic Disease. Human Gene Therapy. 28(7). 551–564. 9 indexed citations
2.
Aronovich, Elena L., Erik R. Olson, Jason Bell, et al.. (2017). Transgene Expression in Dogs After Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters. Human Gene Therapy. 28(7). 541–550. 11 indexed citations
3.
Dickinson, Sally E., Karen Blohm‐Mangone, Erik R. Olson, et al.. (2016). Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin. Cancer Prevention Research. 9(3). 215–224. 16 indexed citations
4.
Podetz-Pedersen, Kelly M., Erik R. Olson, Nikunj V. Somia, Stephen J. Russell, & R. Scott McIvor. (2016). A Broad Range of Dose Optima Achieve High-level, Long-term Gene Expression After Hydrodynamic Delivery of Sleeping Beauty Transposons Using Hyperactive SB100x Transposase. Molecular Therapy — Nucleic Acids. 5. e279–e279. 4 indexed citations
5.
Podetz-Pedersen, Kelly M., Erik R. Olson, Roland Günther, et al.. (2015). Role of Transgene Regulation in Ex Vivo Lentiviral Correction of Artemis Deficiency. Human Gene Therapy. 26(4). 232–243. 8 indexed citations
6.
Hackett, Perry B., Elena L. Aronovich, Jason Bell, et al.. (2015). 126. Non-Viral Gene Therapy By Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons to Treat Hemophilia and Mucopolysaccharidoses in Dogs. Molecular Therapy. 23. S52–S52. 1 indexed citations
7.
Dickinson, Sally E., et al.. (2014). A novel chemopreventive mechanism for a traditional medicine: East Indian sandalwood oil induces autophagy and cell death in proliferating keratinocytes. Archives of Biochemistry and Biophysics. 558. 143–152. 28 indexed citations
8.
Moriarity, Branden S., Eric P. Rahrmann, Caitlin B. Conboy, et al.. (2014). Simple and Efficient Methods for Enrichment and Isolation of Endonuclease Modified Cells. PLoS ONE. 9(5). e96114–e96114. 25 indexed citations
9.
Dickinson, Sally E., Erik R. Olson, Jack Zhang, et al.. (2011). p38 MAP kinase plays a functional role in UVB‐Induced mouse skin carcinogenesis. Molecular Carcinogenesis. 50(6). 469–478. 51 indexed citations
10.
Olson, Erik R., Karl J. Clark, Elena L. Aronovich, et al.. (2011). Sleeping Beauty‐mediated correction of Fanconi anemia type C. The Journal of Gene Medicine. 13(9). 462–469. 16 indexed citations
11.
Chandramouli, Anupama, Melania E. Mercado-Pimentel, Anthony J. Hutchinson, et al.. (2010). The induction of S100p expression by the Prostaglandin E2(PGE2)/EP4 receptor signaling pathway in colon cancer cells. Cancer Biology & Therapy. 10(10). 1056–1066. 39 indexed citations
12.
Beilke, Lisa, Lauren M. Aleksunes, Erik R. Olson, et al.. (2009). Decreased apoptosis during CAR-mediated hepatoprotection against lithocholic acid-induced liver injury in mice. Toxicology Letters. 188(1). 38–44. 17 indexed citations
13.
14.
Shamhart, Patricia E., Daniel J. Luther, Erik R. Olson, et al.. (2008). Cardiac myofibroblast differentiation is attenuated by α3 integrin blockade: Potential role in post-MI remodeling. Journal of Molecular and Cellular Cardiology. 46(2). 186–192. 34 indexed citations
15.
Olson, Erik R., Patricia E. Shamhart, Jennifer E. Naugle, & J. Gary Meszaros. (2008). Angiotensin II-Induced Extracellular Signal-Regulated Kinase 1/2 Activation Is Mediated by Protein Kinase Cδ and Intracellular Calcium in Adult Rat Cardiac Fibroblasts. Hypertension. 51(3). 704–711. 95 indexed citations
16.
Olson, Erik R., et al.. (2008). Stabilization of Quercetin Paradoxically Reduces Its Proapoptotic Effect on UVB-Irradiated Human Keratinocytes. Cancer Prevention Research. 1(5). 362–368. 20 indexed citations
17.
Shamhart, Patricia E., et al.. (2007). Cardiac Fibroblast Migration During In Vitro Wound Healing: The Role Of Specific Collagen Substrates. The FASEB Journal. 21(6). 2 indexed citations
18.
Naugle, Jennifer E., Erik R. Olson, Xiaojin Zhang, et al.. (2005). Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 290(1). H323–H330. 130 indexed citations
19.
Olson, Erik R., Jennifer E. Naugle, Xiaojin Zhang, Joshua A. Bomser, & J. Gary Meszaros. (2004). Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. American Journal of Physiology-Heart and Circulatory Physiology. 288(3). H1131–H1138. 135 indexed citations
20.
Swaney, James S., David M. Roth, Erik R. Olson, et al.. (2004). Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proceedings of the National Academy of Sciences. 102(2). 437–442. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meimei Yin Breakdown of academic impact, for papers by Michal Entin‐Meer Breakdown of academic impact, for papers by Somy Yoon Breakdown of academic impact, for papers by Jianyuan Chai Breakdown of academic impact, for papers by Balkrishna Chaube Breakdown of academic impact, for papers by Kwang Seok Kim Breakdown of academic impact, for papers by Dennis A. Ricupero Breakdown of academic impact, for papers by Jianhua Cui Breakdown of academic impact, for papers by Jiongyu Hu
Rankless by CCL
2026